Lamotrigine Neuraxpharm (Lamotrigine)

Lamotrigine works by blocking voltage‑gated sodium channels on neuronal membranes, which stabilises the cells and reduces the release of excitatory neurotransmitters such as glutamate. This dampening of neuronal hyper‑excitability underlies its antiepileptic and mood‑stabilising effects.

The appropriate dose of lamotrigine is individualised by the prescribing clinician based on the patient’s condition, age, concomitant medications and renal or hepatic function. Dosage regimens are not standardised and should follow the prescriber’s instructions.

Lamotrigine’s pregnancy category is listed as unknown, and limited data exist on its safety during lactation. Women who are pregnant, planning pregnancy, or breastfeeding should discuss potential risks and benefits with their healthcare provider before starting or continuing therapy.

To place an order, submit an enquiry on the product page at gnhindia.com specifying the required quantity. GNH India supplies hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Compared with carbamazepine, another common anticonvulsant, lamotrigine has a lower risk of inducing hepatic enzyme activity and fewer drug‑interaction concerns with oral contraceptives. However, lamotrigine requires slower titration to minimise rash risk, whereas carbamazepine may cause more sedation and hyponatraemia.

Lamotrigine tablets should be stored at ambient temperature, below 25 °C, in the original blister pack or container. Protect the product from moisture, excessive heat and direct sunlight to maintain stability throughout its shelf life.

Lamotrigine is taken orally, usually as a tablet swallowed whole with water. It may be taken with or without food, but consistency with meals can help reduce gastrointestinal upset. The exact schedule and titration are determined by the prescribing clinician.

The most serious adverse reactions include severe skin conditions such as Stevens‑Johnson syndrome or toxic epidermal necrolysis, which require immediate medical attention. Other rare but serious risks are aseptic meningitis, blood dyscrasias like agranulocytosis, and hypersensitivity reactions.

Lamotrigine is contraindicated in individuals with a known hypersensitivity to the drug or any of its components. Patients with severe hepatic impairment should avoid use, and caution is advised in those with a history of serious skin reactions or in combination with certain enzyme‑inducing antiepileptics.